>_ QFI Terminal
TerminalStocks › KVUE

Kenvue Inc. (KVUE) Stock

Consumer Defensive · Household & Personal Products · US
$17.81 -0.34%
Last updated Sep 20, 2026 13:47 UTC

KVUE Key Statistics

Market Cap$34.20B
P/E (TTM)20.47
P/S (TTM)2.22
P/B (TTM)3.24
Revenue (TTM)$15.41B
EPS (TTM)$0.87
Dividend Yield
ROE (TTM)15.58%
Net Margin10.76%
Gross Margin58.19%
52W High$20.13
52W Low$14.02
Analyst ViewHold
Price Target$19.50
Employees21,890
Volume26,706,109

About Kenvue Inc.

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

CEO: Kirk L. Perry. Company website

KVUE — Frequently Asked Questions

What is the KVUE stock price today?

Kenvue Inc. (KVUE) trades at $17.81, down 0.34% on the day, as of Sep 20, 2026 13:47 UTC.

What is Kenvue Inc.'s market cap?

Kenvue Inc. has a market capitalisation of $34.20B, calculated from the live KVUE share price and shares outstanding.

What is the P/E ratio of KVUE?

KVUE trades at a trailing P/E of 20.47, from earnings per share of $0.87 over the last twelve months.

How much revenue does Kenvue Inc. make?

Kenvue Inc. generated revenue of $15.41B over the trailing twelve months, which puts the stock at 2.22 times sales.

What is the 52-week range for KVUE?

KVUE has traded between $14.02 and $20.13 over the past 52 weeks, and the last price is 11.5% below that high.

Is Kenvue Inc. profitable?

Yes. Kenvue Inc. keeps 10.76% of revenue as net income over the trailing twelve months.

What is the analyst price target for KVUE?

Wall Street analysts rate KVUE Hold, with an average price target of $19.50, 9.5% above the current price.

What sector is Kenvue Inc. in?

Kenvue Inc. is classified under the Consumer Defensive sector and the Household & Personal Products industry, and is domiciled in US.

Who is the CEO of Kenvue Inc.?

Kirk L. Perry is the chief executive of Kenvue Inc., which employs 21,890 people.

Where can I track KVUE in real time?

QFI Terminal shows KVUE with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See KVUE live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open KVUE in Terminal See plans

Household & Personal Products stocks

PG The Procter & Gamble Company UL Unilever PLC CL Colgate-Palmolive Company KMB Kimberly-Clark Corporation EL The Estée Lauder Companies Inc. NWL Newell Brands Inc. CLX The Clorox Company CHD Church & Dwight Co., Inc.

More Consumer Defensive stocks

CCU Compañía Cervecerías Unidas S.A. WMT Walmart Inc. JBS Jbs N.V. COST Costco Wholesale Corporation WYHG Wing Yip Food Holdings Group Limited American Depositary Shares KR The Kroger Co. TGT Target Corporation PEP PepsiCo, Inc.